Correction: Oncogenic RAS -induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.

Autor: Vizioli MG; Molecular Mechanism Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Santos J; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Pilotti S; Laboratory of Molecular Pathology, Department of Pathology, IRCCS Foundation - Istituto Nazionale dei Tumori, Milan, Italy., Mazzoni M; Molecular Mechanism Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Anania MC; Molecular Mechanism Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Miranda C; Molecular Mechanism Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pagliardini S; Molecular Mechanism Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pierotti MA; Scientific Directorate, IRCCS Foundation - Istituto Nazionale dei Tumori, Milan, Italy., Gil J; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.; Senior co-authors., Greco A; Molecular Mechanism Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Senior co-authors.

Publikováno v: Oncotarget [Oncotarget] 2022 Oct 14; Vol. 13, pp. 1120-1121. Date of Electronic Publication: 2022 Oct 14.

COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death.

Autor: Di Marco T; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. Electronic address: tiziana.dimarco@istitutotumori.mi.it., Bianchi F; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. Electronic address: francesca.bianchi@istitutotumori.mi.it., Sfondrini L; Dipartimento di Scienze Biomediche per La Salute, University of Milan, Via Mangiagalli, 31, 20133, Milan, Italy. Electronic address: lucia.sfondrini@unimi.it., Todoerti K; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122, Milan, Italy. Electronic address: katiatodoerti@gmail.com., Bongarzone I; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. Electronic address: italia.bongarzone@istitutotumori.mi.it., Maffioli EM; Department of Veterinary Medicine, University of Milan, Via Celoria, 10, 20133, Milan, Italy. Electronic address: Elisa.Maffioli@unimi.it., Tedeschi G; Department of Veterinary Medicine, University of Milan, Via Celoria, 10, 20133, Milan, Italy; Fondazione Filarete, Via Celoria, 10, 20133, Milan, Italy. Electronic address: gabriella.tedeschi@unimi.it., Mazzoni M; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. Electronic address: mara.mazzoni@istitutotumori.mi.it., Pagliardini S; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. Electronic address: sonia.pagliardini@istitutotumori.mi.it., Pellegrini S; Institut Pasteur, Unit of Cytokine Signaling, Inserm U1221, 75724, Paris, France. Electronic address: sandra.pellegrini@pasteur.fr., Neri A; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Italy Via Francesco Sforza, 35, 20122, Milan, Italy. Electronic address: antonino.neri@unimi.it., Anania MC; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. Electronic address: mariachiara.anania@istitutotumori.mi.it., Greco A; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. Electronic address: angela.greco@istitutotumori.mi.it.

Publikováno v: Cancer letters [Cancer Lett] 2020 Apr 28; Vol. 476, pp. 106-119. Date of Electronic Publication: 2020 Feb 14.

Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism.

Autor: Mazzoni M; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Mauro G; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Erreni M; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy. marco.erreni@humanitasresearch.it., Romeo P; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Minna E; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Vizioli MG; Beatson Institute for Cancer Research, Bearsden, Glasgow, UK.; Institute of Cancer Sciences College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G61 1BD, UK., Belgiovine C; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy., Rizzetti MG; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Pagliardini S; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Avigni R; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy., Anania MC; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Allavena P; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy., Borrello MG; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy., Greco A; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. angela.greco@istitutotumori.mi.it.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2019 May 21; Vol. 38 (1), pp. 208. Date of Electronic Publication: 2019 May 21.

La calprotectina fecale nei pazienti con malattie infiammatorie intestinali. Giornale di Gastroenterologia 2002;7:152-155

Autor: Zippi, M, Maffia, C, Anania, Mc, Zanninelli, G, Latella, Giovanni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3983::3a2bd986818e9aa358a690c71f8895bb
http://hdl.handle.net/11697/1264

Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells.

Autor: Anania MC; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Cetti E; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Lecis D; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Todoerti K; Laboratory of Pre-Clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy., Gulino A; Department of Health Science, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Mauro G; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Di Marco T; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Cleris L; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Pagliardini S; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Manenti G; Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Belmonte B; Department of Health Science, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Tripodo C; Department of Health Science, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Neri A; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Greco A; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Electronic address: angela.greco@istitutotumori.mi.it.

Publikováno v: Cancer letters [Cancer Lett] 2017 Dec 01; Vol. 410, pp. 201-211. Date of Electronic Publication: 2017 Sep 23.